The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy
Open accessAbstract
G 4 C 2 repeat–derived poly(GR) plays a key role in mediating TDP-43 mislocalization and aggregation in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“findings from molecular studies indicate that the mechanisms underlying TDP‐43 aggregation by C9orf72 expansions differ from those driven by GRN loss of function. 125 , 126”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
Self-citationA Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Elden, A. C., Kim, H.-J., Hart, M. P., Chen‐Plotkin, A. S., Johnson, B. S., Fang, X., Armakola, M., Geser, F., Greene, R. A., Lu, M. M., et al. (2010) · Nature · doi:10.1038/nature09320 · Cited by 1,361
Neurofilament light chain as a biomarker in neurological disorders
Gaetani, L., Blennow, K., Calabresi, P., Di Filippo, M., Parnetti, L., & Zetterberg, H. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320106 · Cited by 1,334
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Broeckhoven, C. V., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,248
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,127
Self-citationThe C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang, K., Donnelly, C. J., Haeusler, A. R., Grima, J. C., Machamer, J. B., Steinwald, P., Daley, E. L., Miller, S. J., Cunningham, K. M., Vidensky, S., et al. (2015) · Nature · doi:10.1038/nature14973 · Cited by 982
GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport
Freibaum, B. D., Lu, Y., Lopez-Gonzalez, R., Kim, N. C., Almeida, S., Lee, K.-H., Badders, N., Valentine, M., Miller, B. L., Wong, P. C., et al. (2015) · Nature · doi:10.1038/nature14974 · Cited by 841
Self-citation
Cited by
Sorted by citations
Feldman, E. L., Goutman, S. A., Petri, S., Mazzini, L., Savelieff, M. G., Shaw, P. J., & Sobue, G. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01272-7 · Cited by 1,267
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis
Goutman, S. A., Hardiman, O. M., Al‐Chalabi, A., Chiò, A., Savelieff, M. G., Kiernan, M. C., & Feldman, E. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00414-2 · Cited by 432
Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide
Tran, H., Moazami, M. P., Yang, H., McKenna-Yasek, D., Douthwright, C. L., Pinto, C., Metterville, J., Shin, M., Sanil, N., Dooley, C., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01557-6 · Cited by 174
Intra-condensate demixing of TDP-43 inside stress granules generates pathological aggregates
Yan, X., Kuster, D., Mohanty, P., Nijssen, J., García, K. P., Morato, J. G., Rizuan, A., Franzmann, T. M., Sergeeva, A. V., Ly, A. M., et al. (2025) · Cell · doi:10.1016/j.cell.2025.04.039 · Cited by 182
Self-citationHigher-order organization of biomolecular condensates
Fare, C. M., Villani, A., Drake, L. E., & Shorter, J. (2021) · Open Biology · doi:10.1098/rsob.210137 · Cited by 176
Self-citationAltman, T., Ionescu, A., Ibraheem, A., Priesmann, D., Gradus, T., Farberov, L., Alexandra, G., Shelestovich, N., Dafinca, R., Shomron, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27221-8 · Cited by 146
Mehta, A. R., Gregory, J. M., Dando, O., Carter, R. N., Burr, K., Nanda, J., Story, D., McDade, K., Smith, C., Morton, N. M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02252-5 · Cited by 122
Millar, S. R., Huang, J. Q., Schreiber, K. J., Tsai, Y.-C., Won, J., Zhang, J., Moses, A. M., & Youn, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00608 · Cited by 133
Hutten, S., Usluer, S., Bourgeois, B. M. R., Simonetti, F., Odeh, H. M., Fare, C. M., Czuppa, M., Hruška-Plocháň, M., Hofweber, M., Polymenidou, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108538 · Cited by 110
Self-citationNuclear pore complexes — a doorway to neural injury in neurodegeneration
Coyne, A. N., & Rothstein, J. D. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00653-6 · Cited by 96
Gupta, M. N., & Uversky, V. N. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128646 · Cited by 92
Fumagalli, L., Young, F. L., Boeynaems, S., Decker, M. D., Mehta, A. R., Swijsen, A., Fazal, R., Guo, W., Moisse, M., Beckers, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg3013 · Cited by 94
Self-citationCellular and physiological functions of C9ORF72 and implications for ALS/FTD
Pang, W., & Hu, F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15255 · Cited by 95
Combating deleterious phase transitions in neurodegenerative disease
Darling, A. L., & Shorter, J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118984 · Cited by 88
Self-citationFriend or foe: The role of stress granule in neurodegenerative disease
Cui, Q., Liu, Z., & Bai, G. (2024) · Neuron · doi:10.1016/j.neuron.2024.04.025 · Cited by 86
Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration
Shao, W., Todd, T. W., Wu, Y., Jones, C. Y., Tong, J., Jansen‐West, K. R., Daughrity, L. M., Park, J., Koike, Y. M., Kurti, A., et al. (2022) · Science · doi:10.1126/science.abq7860 · Cited by 83
Self-citationTDP-43 pathology: From noxious assembly to therapeutic removal
Keating, S. S., Gil, R. S., Swanson, M. E. V., Scotter, E. L., & Walker, A. K. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102229 · Cited by 81
Masrori, P., Beckers, J., Gossye, H., & Damme, P. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00525-z · Cited by 80
TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Bright, F., Chan, G., van Hummel, A., Ittner, L. M., & Ke, Y. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157781 · Cited by 71
NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility
Gleixner, A. M., Verdone, B. M., Otte, C. G., Anderson, E. N., Ramesh, N., Shapiro, O. R., Gale, J. R., Mauna, J. C., Mann, J. R., Copley, K. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31098-6 · Cited by 71
Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD
Schmitz, A., Marques, J. P., Oertig, I., Maharjan, N., & Saxena, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.637548 · Cited by 70
Connecting TDP-43 Pathology with Neuropathy
Klim, J. R., Pintacuda, G., Nash, L. A., Juan, I. G. S., & Eggan, K. C. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.02.008 · Cited by 70
Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids
Tamaki, Y., Ross, J. P., Alipour, P., Castonguay, C.-E., Li, B., Catoire, H., Rochefort, D. L., Urushitani, M., Takahashi, R., Sonnen, J. A., et al. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010606 · Cited by 67
Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia
Marques, C., Held, A., Dorfman, K., Sung, J., Song, C., Kavuturu, A. S., Aguilar, C., Russo, T., Oakley, D. H., Albers, M. W., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02688-z · Cited by 68
Self-citationMitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis
Genin, E. C., Abou-Ali, M., & Paquis‐Flucklinger, V. (2023) · Genes · doi:10.3390/genes14111981 · Cited by 64
Principles and functions of condensate modifying drugs
Patel, A., Mitrea, D. M., Namasivayam, V., Murcko, M. A., Wagner, M., & Klein, I. A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1007744 · Cited by 62
Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology
Anderson, E. N., Morera, A. A., Kour, S., Cherry, J. D., Ramesh, N., Gleixner, A., Schwartz, J. C., Ebmeier, C., Old, W., Donnelly, C. J., et al. (2021) · eLife · doi:10.7554/elife.67587 · Cited by 61
Prion-Like Proteins in Phase Separation and Their Link to Disease
Sprunger, M. L., & Jackrel, M. E. (2021) · Biomolecules · doi:10.3390/biom11071014 · Cited by 60
Update on genetics of amyotrophic lateral sclerosis
Brenner, D., & Freischmidt, A. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001093 · Cited by 56
del Campo, M., Zetterberg, H., Gandy, S., Onyike, C. U., Oliveira, F., Udeh‐Momoh, C., Lleó, A., Teunissen, C. E., & Pijnenburg, Y. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12643 · Cited by 52
Integrative genetic analysis illuminates ALS heritability and identifies risk genes
Megat, S., Mora, N., Sanogo, J., Roman, O., Catanese, A., Alami, N. O., Freischmidt, A., Mingaj, X., de Calbiac, H., Muratet, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35724-1 · Cited by 53
Mizielinska, S., Hautbergue, G. M., Gendron, T. F., van Blitterswijk, M., Hardiman, O. M., Ravits, J., Isaacs, A. M., & Rademakers, R. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00026-2 · Cited by 54
Self-citationDNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders
Provasek, V. E., Mitra, J., Malojirao, V. H., & Hegde, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094653 · Cited by 54
Ryan, S., Rollinson, S. J., Hobbs, E., & Pickering-Brown, S. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-08724-w · Cited by 49
Guo, Y., Chen, J., Ji, W., Xu, L., Xie, Y., He, S., Lai, C., Hou, K., Li, Z., Chen, G., et al. (2023) · Molecular Therapy Methods & Clinical Development · doi:10.1016/j.omtm.2023.08.021 · Cited by 47
Khalil, B., Chhangani, D., Wren, M. C., Smith, C. L., Lee, J. H., Li, X., Puttinger, C., Tsai, C.-W., Fortin, G., Morderer, D., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00585-1 · Cited by 50
Self-citationAmyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises
McAlary, L., Chew, Y. L., Lum, J. S., Geraghty, N. J., Yerbury, J. J., & Cashman, N. R. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.581907 · Cited by 48
He, D., Xu, Y. C., Liu, M., & Cui, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0519 · Cited by 44
Liu, F., Morderer, D., Wren, M. C., Vettleson-Trutza, S. A., Wang, Y., Rabichow, B. E., Salemi, M., Phinney, B. S., Oskarsson, B., Dickson, D. W., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01322-x · Cited by 46
Self-citationMilioto, C., Carcolé, M., Giblin, A., Coneys, R., Attrebi, O. N., Ahmed, M., Harris, S., Lee, B. I., Yang, M., Ellingford, R. A., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01589-4 · Cited by 46
The mechanisms, hallmarks, and therapies for brain aging and age-related dementia
Jin, S., Lü, W., Zhang, J., Zhang, L., Tao, F., Zhang, Y., Hu, X., & Liu, Q. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2024.09.005 · Cited by 41
Self-citationModelling amyotrophic lateral sclerosis in rodents
Todd, T. W., & Petrucelli, L. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00564-x · Cited by 44
Self-citationRegulation of Biomolecular Condensates by Poly(ADP-ribose)
Rhine, K., Odeh, H. M., Shorter, J., & Myong, S. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00851 · Cited by 40
Self-citationNeuronal polyunsaturated fatty acids are protective in ALS/FTD
Giblin, A., Cammack, A. J., Blomberg, N., Anoar, S., Mikheenko, A., Carcolé, M., Atilano, M. L., Hull, A. J., Shen, D., Wei, X., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01889-3 · Cited by 40
Qin, C., Wang, Y., Zheng, J., Wan, X., & Fan, X. (2025) · BMC Biology · doi:10.1186/s12915-025-02214-x · Cited by 39
Approaches to gene modulation therapy for ALS
Meijboom, K. E., & Brown, R. H. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01285-w · Cited by 38
Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis
Jankovic, M., Novakovic, I., Gamil Anwar Dawod, P., Gamil Anwar Dawod, A., Drinic, A., Abdel Motaleb, F. I., Ducic, S., & Nikolic, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189832 · Cited by 36
Autophagy Dysfunction in ALS: from Transport to Protein Degradation
Cozzi, M., & Ferrari, V. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02029-3 · Cited by 38
Yang, T., Hou, Y., Li, C., Cao, B., Cheng, Y., Wei, Q., Zhang, L., & Shang, H. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325701 · Cited by 34
Anoar, S., Woodling, N. S., & Niccoli, T. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.786076 · Cited by 37
Neuronal biomolecular condensates and their implications in neurodegenerative diseases
Nam, J., & Gwon, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1145420 · Cited by 34
Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD
Khalil, B., Linsenmeier, M., Smith, C. L., Shorter, J., & Rossoll, W. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00698-1 · Cited by 33
Self-citationVerde, E. M., Secco, V., Ghezzi, A., Mandrioli, J., & Carra, S. (2025) · Cells · doi:10.3390/cells14100680 · Cited by 35
Papendorf, J. J., Krüger, E., & Ebstein, F. (2022) · Cells · doi:10.3390/cells11091422 · Cited by 34
SUMO2/3 conjugation of TDP-43 protects against aggregation
Verde, E. M., Antoniani, F., Mediani, L., Secco, V., Crotti, S., Ferrara, M. C., Vinet, J., Sergeeva, A. V., Yan, X., Hoege, C., et al. (2025) · Science Advances · doi:10.1126/sciadv.adq2475 · Cited by 31
Frottin, F., Pérez‐Berlanga, M., Hartl, F. U., & Hipp, M. S. (2021) · eLife · doi:10.7554/elife.62718 · Cited by 33
Copper toxicity and deficiency: the vicious cycle at the core of protein aggregation in ALS
Min, J.-H., Sarlus, H., & Harris, R. A. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1408159 · Cited by 31
Altered Phase Separation and Cellular Impact in C9orf72-Linked ALS/FTD
Solomon, D. A., Smikle, R., Reid, M. J., & Mizielinska, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.664151 · Cited by 33
Pathological phase transitions in ALS-FTD impair dynamic RNA–protein granules
Nedelsky, N. B., & Taylor, J. P. (2021) · RNA · doi:10.1261/rna.079001.121 · Cited by 31
Park, J., Wu, Y., Shao, W., Gendron, T. F., van der Spek, S. J. F., Sultanakhmetov, G., Basu, A., Otero, P. C., Jones, C. J., Jansen‐West, K. R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112822 · Cited by 30
Self-citationAikio, M., Odeh, H. M., Wobst, H. J., Lee, B. L., Chan, Ú., Mauna, J. C., Mack, K. L., Class, B., Ollerhead, T. A., Ford, A. F., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115205 · Cited by 30
Self-citationAberrant Stress Granule Dynamics and Aggrephagy in ALS Pathogenesis
Zhang, Y., Gu, J., & Sun, Q. (2021) · Cells · doi:10.3390/cells10092247 · Cited by 28
Self-citationMcGoldrick, P., Lau, A., You, Z., Durcan, T. M., & Robertson, J. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112134 · Cited by 29
Intercellular transmission of pathogenic proteins in ALS: Exploring the pathogenic wave
Arnold, F. J., Nguyen, A., Bedlack, R., Bennett, C. L., & Spada, A. R. L. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106218 · Cited by 29
Ho, P., Hsieh, T., & Tsai, K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102441 · Cited by 28
Poly(ADP-ribose) promotes toxicity of C9ORF72 arginine-rich dipeptide repeat proteins
Gao, J., Mewborne, Q. T., Girdhar, A., Sheth, U., Coyne, A. N., Punathil, R., Kang, B. G., Dasovich, M., Veire, A. M., Hernandez, M. D., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq3215 · Cited by 26
Self-citationLefebvre-Omar, C., Liu, E., Dalle, C., d’Incamps, B. L., Bigou, S., Daube, C., Karpf, L., Davenne, M., Robil, N., Jost-Mousseau, C., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04797-6 · Cited by 28
Jiang, L., Zhang, X.-L., & Hu, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212380 · Cited by 25
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis
Michaelis, T., Arlehamn, C. S. L., Johansson, E., Frazier, A., Williams, G. P., Berry, J. D., Cudkowicz, M., Goyal, N., Fournier, C. N., Snyder, A., et al. (2025) · Nature · doi:10.1038/s41586-025-09588-6 · Cited by 24
Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis
Nguyen, L. (2024) · Cells · doi:10.3390/cells13110888 · Cited by 29
Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis
Jacob, S. M., Lee, S., Kim, S. H., Sharkey, K. A., Pfeffer, G., & Nguyen, M. D. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00991-7 · Cited by 25
Verdone, B. M., Cicardi, M. E., Wen, X., Sriramoji, S., Russell, K. A., Markandaiah, S. S., Jensen, B. K., Krishnamurthy, K., Haeusler, A. R., Pasinelli, P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09593-z · Cited by 23
Dong, D., Zhang, Z., Li, Y., Latallo, M. J., Wang, S., Nelson, B., Wu, R., Krishnan, G., Gao, F., Wu, B., et al. (2024) · Science Signaling · doi:10.1126/scisignal.adl1030 · Cited by 22
Kou, W., Li, S., Yan, R., Zhang, J., Wan, Z., & Feng, T. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13051-x · Cited by 22
Jiang, X., Schaeffer, L., Patni, D., Russo, T., Lee, C.-Z., Aguilar, C., Marques, C., Jansen‐West, K. R., Hruška-Plocháň, M., Ray-Soni, A., et al. (2026) · Science · doi:10.1126/science.adv2600 · Cited by 22
Self-citationMori, K., Gotoh, S., Yamashita, T., Uozumi, R., Kawabe, Y., Tagami, S., Kamp, F., Nuscher, B., Edbauer, D., Haass, C., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101120 · Cited by 23
Nuclear-Import Receptors Counter Deleterious Phase Transitions in Neurodegenerative Disease
Odeh, H. M., Fare, C. M., & Shorter, J. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167220 · Cited by 22
Self-citationLSM12-EPAC1 defines a neuroprotective pathway that sustains the nucleocytoplasmic RAN gradient
Lee, J., Park, J., Kim, J.-H., Lee, G., Park, T., Yoon, K., Kim, Y. K., & Lim, C. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3001002 · Cited by 22
Multi-phaseted problems of TDP-43 in selective neuronal vulnerability in ALS
Asakawa, K., Handa, H., & Kawakami, K. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03792-z · Cited by 20
Frontotemporal Dementia and Glucose Metabolism
Garrett, L. R., & Niccoli, T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.812222 · Cited by 20
Partners in crime: Proteins implicated in RNA repeat expansion diseases
Baud, A., Derbis, M., Tutak, K., & Sobczak, K. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1709 · Cited by 20
Sahana, T. G., Chase, K. J., Liu, F., Lloyd, T. E., Rossoll, W., & Zhang, K. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1799-22.2023 · Cited by 21
Unraveling the impact of disrupted nucleocytoplasmic transport systems in C9orf72-associated ALS
McGoldrick, P., & Robertson, J. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1247297 · Cited by 22
Nuclear pore dysfunction and disease: a complex opportunity
Fare, C. M., & Rothstein, J. D. (2024) · Nucleus · doi:10.1080/19491034.2024.2314297 · Cited by 21
Rifai, O. M., Longden, J., O’Shaughnessy, J., Sewell, M. D. E., Pate, J. A., McDade, K., Daniels, M. J. D., Abrahams, S., Chandran, S., McColl, B. W., et al. (2022) · The Journal of Pathology · doi:10.1002/path.6008 · Cited by 20
p53 Transactivation Domain Mediates Binding and Phase Separation with Poly-PR/GR
Usluer, S., Spreitzer, E., Bourgeois, B. M. R., & Madl, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111431 · Cited by 19
Amalyan, S., Tamboli, S., Lazarevich, I. A., Topolnik, D., Bouman, L. H., & Topolnik, L. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111043 · Cited by 19
Graphene Quantum Dots Attenuate TDP-43 Proteinopathy in Amyotrophic Lateral Sclerosis
Park, N.-Y., Heo, Y., Yang, J. W., Yoo, J. M., Jang, H. J., Jo, J. H., Park, S. J., Lin, Y., Choi, J., Jeon, H., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c15283 · Cited by 20
Loss of PML nuclear bodies in familial amyotrophic lateral sclerosis-frontotemporal dementia
Antoniani, F., Cimino, M., Mediani, L., Vinet, J., Verde, E. M., Secco, V., Yamoah, A., Tripathi, P., Aronica, E., Cicardi, M. E., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01547-2 · Cited by 19
Saloner, R., Staffaroni, A. M., Dammer, E. B., Johnson, E. C. B., Paolillo, E. W., Wise, A. B., Heuer, H. W., Forsberg, L. K., Lario‐Lago, A., Webb, J. D., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00878-2 · Cited by 21
Self-citationC9orf72 poly-PR forms anisotropic condensates causative of nuclear TDP-43 pathology
Hodgson, R. E., Rayment, J. A., Huang, W.-P., Avila, A. S., Ellis, B. C. S., Lin, Y.-H., Soni, N., Hautbergue, G. M., & Shelkovnikova, T. A. (2024) · iScience · doi:10.1016/j.isci.2024.110937 · Cited by 17
Short RNA chaperones promote aggregation-resistant TDP-43 conformers to mitigate neurodegeneration
Copley, K. E., Mauna, J. C., Danielson, H. L., Chen, Q., Ozguney, B., Ngo, M., Xie, L., Smirnov, A., Davis, M., Mayne, L., et al. (2026) · Science · doi:10.1126/science.adv3301 · Cited by 16
Self-citationRepeated mild traumatic brain injury triggers pathology in asymptomatic C9ORF72 transgenic mice
Kahriman, A., Bouley, J., Tuncali, I., Dogan, E. O., Pereira, M., Luu, T., Bosco, D. A., Jaber, S., Peters, O. M., Brown, R. H., et al. (2023) · Brain · doi:10.1093/brain/awad264 · Cited by 18
Ko, Y., Lokareddy, R. K., Doll, S. G., Yeggoni, D. P., Girdhar, A., Mawn, I., Klim, J. R., Rizvi, N. F., Meyers, R. E., Gillilan, R. E., et al. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168751 · Cited by 16
Xu, L., Wang, D., Zhao, L., Yang, Z., Liu, X., Li, X., Yuan, T., Wang, Y., Huang, T., Bian, N., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106197 · Cited by 16
Interaction-Dependent Secondary Structure of Peptides in Biomolecular Condensates
Lorenz-Ochoa, K. A., Cho, M., Parekh, S. H., & Baiz, C. R. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c11226 · Cited by 15
Șerban, M., Toader, C., & Covache-Busuioc, R.-A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168072 · Cited by 17
RNA-binding protein dysfunction in neurodegeneration
Popper, B., Scheidt, T., & Schieweck, R. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210024 · Cited by 15
Liu, Q. H., Sun, Y., He, B., Chen, H., Wang, L., Wang, G., Zhang, K., Zhao, X., Zhang, X., Shen, D., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01919-4 · Cited by 14
Zhang, G., Feng, C., & Chu, X. (2025) · JACS Au · doi:10.1021/jacsau.5c00876 · Cited by 14
Metadata
- Authors
- Cook, C. N., Wu, Y., Odeh, H. M., Gendron, T. F., Jansen-West, K., del Rosso, G., Yue, M., Jiang, P., Gomes, E., Tong, J., Daughrity, L. M., Avendano, N. M., Castanedes-Casey, M., Shao, W., Oskarsson, B., Tomassy, G. S., McCampbell, A., Rigo, F., Dickson, D. W., Shorter, J., Zhang, Y.-J., & Petrucelli, L.
- Affiliations
- Mayo Clinic (US)
- University of Pennsylvania (US)
- Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
- Biogen (United States) (US)
- Ionis Pharmaceuticals (United States) (US)
- Corresponding author
- Cook, Casey N.
- Wu, Yanwei
- Odeh, Hana M.
- Shorter, James
- Zhang, Yong-Jie
- Petrucelli, Leonard
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2020-09-02
- Volume
- 12
- Issue
- 559
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC7989020
- OpenAlex
- W3082060010
- Cited by
- 193
- References
- 49
- Citations by year
- 2026: 22 · 2025: 40 · 2024: 27 · 2023: 27 · 2022: 37 · 2021: 36 · 2020: 4
- FWCI
- 11.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R21AG065854)
- National Institute of General Medical Sciences (R01GM099836)
- National Institute of Neurological Disorders and Stroke (R35NS097273, P01NS084974, P01NS099114, R01NS088689)
- Amyotrophic Lateral Sclerosis Association
- Biogen Idec
- Mayo Clinic Foundation
- Robert Packard Center for ALS Research at Johns Hopkins
- Target ALS Foundation
- AstraZeneca post-doctoral fellowship
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- C9orf72, protein aggregation, TDP-43, TDP-43 proteinopathy, amyotrophic lateral sclerosis, disease-modifying therapy, neurofilament light chain, plasma biomarkers, treatment efficacy
- MeSH terms
- C9orf72 Protein, Amyotrophic Lateral Sclerosis, Animals, Disease Models, Animal, DNA-Binding Proteins, DNA Repeat Expansion, Mice, TDP-43 Proteinopathies, Frontotemporal Dementia, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review